ATE308997T1 - Mittel zur behandlung von erkrankungen der speiseröhre - Google Patents

Mittel zur behandlung von erkrankungen der speiseröhre

Info

Publication number
ATE308997T1
ATE308997T1 AT00927500T AT00927500T ATE308997T1 AT E308997 T1 ATE308997 T1 AT E308997T1 AT 00927500 T AT00927500 T AT 00927500T AT 00927500 T AT00927500 T AT 00927500T AT E308997 T1 ATE308997 T1 AT E308997T1
Authority
AT
Austria
Prior art keywords
esophaus
diseases
agents
treatment
Prior art date
Application number
AT00927500T
Other languages
English (en)
Inventor
Peter William Dettmar
Paul Andrew Dickson
Frank Chadwick Hampson
Ian Gordon Jolliffe
Original Assignee
Reckitt Benckiser Healthcare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt Benckiser Healthcare filed Critical Reckitt Benckiser Healthcare
Application granted granted Critical
Publication of ATE308997T1 publication Critical patent/ATE308997T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00927500T 1999-05-05 2000-05-04 Mittel zur behandlung von erkrankungen der speiseröhre ATE308997T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9910212.1A GB9910212D0 (en) 1999-05-05 1999-05-05 Improvements in or relating to organic compositions
PCT/GB2000/001711 WO2000067799A1 (en) 1999-05-05 2000-05-04 Compositions for treatment of disorders of the oesophagus

Publications (1)

Publication Number Publication Date
ATE308997T1 true ATE308997T1 (de) 2005-11-15

Family

ID=10852720

Family Applications (2)

Application Number Title Priority Date Filing Date
AT05019522T ATE417602T1 (de) 1999-05-05 2000-05-04 Mittel zur behandlung von erkrankungen der speiseröhre
AT00927500T ATE308997T1 (de) 1999-05-05 2000-05-04 Mittel zur behandlung von erkrankungen der speiseröhre

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT05019522T ATE417602T1 (de) 1999-05-05 2000-05-04 Mittel zur behandlung von erkrankungen der speiseröhre

Country Status (15)

Country Link
US (1) US6610667B1 (de)
EP (2) EP1173218B1 (de)
JP (1) JP2002544176A (de)
CN (1) CN1173743C (de)
AR (1) AR023876A1 (de)
AT (2) ATE417602T1 (de)
AU (1) AU774966B2 (de)
BR (1) BR0010209A (de)
CA (1) CA2371031C (de)
DE (2) DE69940131D1 (de)
ES (1) ES2251997T3 (de)
GB (2) GB9910212D0 (de)
PL (1) PL199445B1 (de)
WO (1) WO2000067799A1 (de)
ZA (1) ZA200109073B (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2368013B (en) * 2001-02-19 2004-07-28 Richard Orlando Brown An antacid composition which comprise multiple pharmacologically active ingredients for the symptomatic management of pain
GB2398496A (en) * 2003-02-20 2004-08-25 Reckitt Benckiser Healthcare Suspensions of water-swellable polymer particles which are substantially water-free or contain insufficient water to fully swell the particles
US20040185119A1 (en) * 2003-02-26 2004-09-23 Theuer Richard C. Method and compositions for treating gastric hyperacidity while diminishing the likelihood of producing vitamin deficiency
ITRM20030154A1 (it) * 2003-04-03 2004-10-04 D M G Italia S R L Sciroppo antireflusso.
PL1618149T3 (pl) * 2003-04-25 2007-07-31 Reckitt Benckiser Healthcare Zagęszczające się kompozycje
WO2006085987A2 (en) * 2004-07-09 2006-08-17 University Of Iowa Research Foundation Rna interference in respiratory epitheial cells
FR2876581B1 (fr) * 2004-10-20 2007-05-18 Interpharm Dev Composition bioadhesive a liberation programmee
JP4775807B2 (ja) * 2004-12-02 2011-09-21 株式会社 メドレックス 局所麻酔薬物含有ゼリー剤
US8062686B2 (en) 2005-04-12 2011-11-22 InovoBiologics, Inc. Dietary supplement, and methods of use
US8597709B2 (en) * 2005-04-12 2013-12-03 Inovobiologic Inc. Dietary supplement and methods of use
PL1931222T3 (pl) * 2005-10-05 2012-07-31 Technostics Ltd Żelujące kompozycje i sposoby
EP1859786A1 (de) * 2006-05-16 2007-11-28 Frutarom Netherlands B.V. Methode zu vermindern die Symptome von Sodbrennen und Gastro-speiseröhren Rücklaufkrankheit durch spezifischen polysaccharides
BRPI0704542B8 (pt) * 2007-05-15 2021-05-25 Univ Estadual Campinas Unicamp composição farmacêutica, processo de obtenção da composição farmacêutica, uso de uma quantidade farmaceuticamente eficaz de anestésico e agente gelificante, produto e método de tratamento
AU2014262248B2 (en) * 2007-07-30 2017-05-04 Inovobiologic, Inc. Dietary fiber composition comprising glucomannan, xanthan gum, alginate and lipid
US8143314B1 (en) 2007-09-13 2012-03-27 Robert Carl Stover Methods and formulations for treating ineffective or decreased esophageal motility
CA2704949A1 (en) * 2007-11-13 2009-05-22 Meritage Pharma, Inc. Gastrointestinal delivery systems
US20090148530A1 (en) * 2007-12-08 2009-06-11 Jamie Koufman Method for prevention and treatment of reflux injury in the aerodigestive tract and laryngopharynx caused by pepsin
US20090145433A1 (en) * 2007-12-08 2009-06-11 Michael James Apparatus for dispensing a powdered composition into the aerodigestive tract
CA2930063C (en) 2008-01-04 2017-01-31 Schabar Research Associates Llc Unit oral solid dose compositions composed of naproxen sodium and nizatidine
BRPI0906465A2 (pt) * 2008-02-08 2015-07-14 Colgate Palmolive Co Composição efervesente, e, método
ES2405314T3 (es) 2008-05-13 2013-05-30 Apharm S.R.L. Composiciones y uso oral de glicosaminoglicanos
BRPI0912028A2 (pt) * 2008-05-15 2015-10-06 Firmenich & Cie sistema de liberação para um ingrediente ativo.
WO2010108494A1 (en) * 2009-03-25 2010-09-30 S-Biotek Holding Aps Dayspepsia treatment with alginate
PL2435021T3 (pl) 2009-05-25 2014-03-31 Sofar Swiss Sa Zastosowanie połączenia glikozoaminoglikanowego o stałych proporcjach i kompozycji do żucia zawierającej wspomniane połączenie o stałych proporcjach
TR201005241A1 (tr) * 2010-05-25 2012-01-23 Sanovel �La� San. Ve T�C. A.�. Kontrollü salım sağlayan pregabalin solüsyon formülasyonu.
ITRM20120041A1 (it) 2012-02-08 2013-08-09 Dicofarm Spa "prodotto a base di glucomannano e chitosano utile per il trattamento del reflusso gastroesofageo"
US9452135B2 (en) 2012-03-20 2016-09-27 Particle Dynamics International, Llc Gelling agent-based dosage form
US9636360B2 (en) * 2012-09-18 2017-05-02 pH Science Holdings, Inc Method and composition for treating gastro-esophageal disorders
IT201600088648A1 (it) * 2016-08-31 2018-03-03 Alpiflor S R L Composizione nutrizionale o farmaceutica ed integratore alimentare contenente detta compsizione nutrizionale o farmaceutica
IT201600121601A1 (it) * 2016-11-30 2018-05-30 Nekkar Lab Srl Composizione orale per il trattamento del reflusso gastroesofageo e del reflusso laringo-faringeo
IT201600121617A1 (it) * 2016-11-30 2018-05-30 Nekkar Lab Srl Composizione per il trattamento del reflusso gastroesofageo
CN106420773A (zh) * 2016-12-21 2017-02-22 郑州莉迪亚医药科技有限公司 一种治疗放射性肠炎的中西药组合物及其制备方法和应用
IT201700108526A1 (it) 2017-09-28 2019-03-28 Alfasigma Spa Composizioni orali per il trattamento del refluso gastroesofageo.
WO2019169137A1 (en) * 2018-03-02 2019-09-06 Pharagen Llc Formulations treating acid reflux comprising sodium alginate
WO2019172261A1 (ja) * 2018-03-05 2019-09-12 国立大学法人東京大学 食道狭窄防止材料
CN109432233A (zh) * 2018-12-07 2019-03-08 纽湃腾（北京）医药科技有限公司 一种含有猴头菇提取物的抑反流护胃组合物及应用
CN109432232B (zh) * 2018-12-07 2021-11-26 纽湃腾（北京）医药科技有限公司 一种改善调节胃食管反流的海藻酸盐组合物及应用
CN110840853A (zh) * 2019-10-26 2020-02-28 张强 胃镜检查用咀嚼或含化型口咽部局麻药及服用方法
IL299845A (en) 2020-07-15 2023-03-01 Schabar Res Associates Llc Unit oral dose compositions composed of ibuprofen and famotidine for the treatment of acute pain and the reduction of the severity and/or risk of heartburn
US11324727B2 (en) 2020-07-15 2022-05-10 Schabar Research Associates, Llc Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn
IT202000031433A1 (it) * 2020-12-18 2022-06-18 Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L Composizioni comprendenti saccarosio octasolfato per il trattamento del reflusso gastrico
IT202000031409A1 (it) * 2020-12-18 2022-06-18 Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L Composizione multicomponente comprendente gomma gellano e suo uso per il trattamento del reflusso gastrico
EP4262824B1 (de) * 2020-12-18 2025-11-12 Drugs Minerals and Generics Italia S.R.L. In Forma Abbreviata D.M.G. Italia S.R.L. Mehrstoffgemisch enthaltend saccharosesulfat, alginat, gellangummi zur behandlung von magenreflux
IT202000031421A1 (it) * 2020-12-18 2022-06-18 Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L Composizione multicomponente comprendente saccarosio solfato o suoi derivati per il trattamento del reflusso gastrico

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57133170A (en) * 1981-02-12 1982-08-17 Kikusui Kagaku Kogyo Kk Thermochromic coating compound with colorful pattern
US4717713A (en) 1983-10-31 1988-01-05 Research Corporation Controlled release liquid pharmaceutical
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
GB8911177D0 (en) * 1989-05-16 1989-07-05 Vilain Jean Alginate gel pharmaceutical product
DE69231281T2 (de) * 1991-12-17 2001-03-01 Biovail Technologies Ltd.(N.D.Ges.D.Staates Delaware), Chantilly Zusammensetzung und verfahren zur ulcusprävention und -behandlung
GB9322314D0 (en) * 1993-10-29 1993-12-15 Scherer Ltd R P Foam generating capsules
GB9708773D0 (en) 1997-04-30 1997-06-25 Reckitt & Colmann Prod Ltd Organic compositions
US6030641A (en) * 1997-06-03 2000-02-29 Uni Colloid Kabushiki Kaisha Sustained release capsule and method for preparing the same

Also Published As

Publication number Publication date
PL199445B1 (pl) 2008-09-30
DE60023873T2 (de) 2006-08-03
EP1614431B1 (de) 2008-12-17
EP1614431A2 (de) 2006-01-11
CN1173743C (zh) 2004-11-03
GB2349570A (en) 2000-11-08
GB9910212D0 (en) 1999-06-30
AR023876A1 (es) 2002-09-04
AU774966B2 (en) 2004-07-15
CN1349418A (zh) 2002-05-15
GB2349570B (en) 2002-05-22
WO2000067799A1 (en) 2000-11-16
JP2002544176A (ja) 2002-12-24
ZA200109073B (en) 2003-01-29
BR0010209A (pt) 2002-02-19
ATE417602T1 (de) 2009-01-15
ES2251997T3 (es) 2006-05-16
CA2371031C (en) 2008-09-30
PL351134A1 (en) 2003-03-24
GB0010669D0 (en) 2000-06-28
US6610667B1 (en) 2003-08-26
EP1614431A3 (de) 2006-03-01
AU4590000A (en) 2000-11-21
DE60023873D1 (de) 2005-12-15
CA2371031A1 (en) 2000-11-16
EP1173218A1 (de) 2002-01-23
EP1173218B1 (de) 2005-11-09
DE69940131D1 (de) 2009-01-29

Similar Documents

Publication Publication Date Title
ATE308997T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
DE69929996D1 (de) Pharmazeutisches mittel zur behandlung von diabetes
ATE512163T1 (de) Verabreichung von mitteln zur behandlung von entzündungen
ATE305306T1 (de) Reboxetin zur behandlung von peripheren neuropathien
DE69925306D1 (de) Behandlung von kohlenwasserstoffgas
DE69903543D1 (de) Formulierungen zur behandlung von magen-speiseröhren reflux
ATE271038T1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
ATE300597T1 (de) Behandlung von geweben
ATE292134T1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
EP1117431A4 (de) Behandlung von acidose
EP1239851A4 (de) Behandlung von hyperproliferativen erkrankungen
DE69905214D1 (de) Mittel zur Behandlung der Osteoporose
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
DE60018200D1 (de) Verwendung von pleuromutilinderivaten zur transdermalen behandlung bakterieller erkrankungen
DE60021252D1 (de) Antikonvulsiva zur behandlung von autismus
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
ATE230741T1 (de) 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen
DE60017174D1 (de) Rivastigmine zur behandlung von augenerkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties